Introduction
Sunscreens, perfumes and other cosmetics are popular consumer products for all age groups and both genders, worldwide. Ultraviolet (UV) filters are a broad category of chemicals developed to provide skin protection against direct exposure to harmful solar radiation. Their beneficial action is attributed to their ability to absorb the UVA or UVB radiation. The increasing intensity of UV solar radiation during the last years has been manifested in the progressive development of various health outcomes, ranging from simple sunburn to skin cancer [1] . Use of sunscreens appears to be an effective control measure Abstract: Ethylhexyl-methoxy cinnamate (EHMC), an ultraviolet (UV) filter that absorbs solar UVB radiation is frequently used in the formulation of sunscreens and cosmetics. Except for the controlled UV filter application studies, no general population studies on the magnitude and variability of exposures to EHMC exist. Given the widespread use of UV filters in consumer products, a pilot human biomonitoring study was undertaken to: i) determine the concentrations of EHMC in urine samples of young adults, and ii) investigate the association between consumption patterns of selected consumer products and urinary EHMC concentrations. A group of 48 randomlyselected volunteers provided a first morning urine void and a questionnaire on the types and usage patterns of sunscreens and cosmetics was administered to them. Significantly (p=0.006) higher urinary EHMC levels were observed in females, and in users of face sunscreens (p=0.008) and lipsticks (p=0.003). Linear multiple regression analysis showed that the frequency of use of face sunscreens (all year) (p=0.02) and gender (females) (p=0.03) were significant predictors of creatinine-adjusted urinary EHMC levels in the pooled sample, even after adjusting for relevant covariates, such as age, body-mass index and the number of cosmetics used. A larger sample could help us further evaluate the observed trends.
against the adverse health effects of sun UV exposure [2] . However, an increasing controversy is observed about possible health effects of UV filters and other constituents of cosmetics because of recent studies highlighting the endocrine-disrupting properties of certain UV filters found in common cosmetics and personal care products (PCPs) [3, 4] .
UV filters include a large group of organic compounds, such as benzophenones and cinnamates, and inorganic compounds, such as titanium dioxide and zinc oxide. The organic UV filters usually have single or multiple aromatic structures, consisting of either carbon-carbon double bonds or carbonyl moieties. Their action entails the absorption of solar photons and subsequent emission of thermal energy, allowing them to return again to the earlier ground state via a sequence of vibrational transitions [3] . Octyl-methoxy cinnamate, or ethylhexylmethoxy cinnamate (EHMC) according to the International Nomenclature of Cosmetic Ingredients is extensively used as a filter against UVB radiation. It belongs to the list of 27 UV filters that are approved for use, up to 10% (w/w), in cosmetics formulations marketed in the European Union [5] [6] [7] . On the contrary, the respective number of approved compounds in the USA is much smaller and sunscreens are considered as pharmaceuticals that are sold over-the-counter. According to the US Food and Drug Administration, EHMC is an approved UV filter with its maximum permitted concentration set at 7.5% w/w [8] . In addition to its use in sunscreens, EHMC is included in other PCPs formulations, such as lipsticks, foundations and aftershaves. EHMC is not as photostable as other UV filters, such as octocrylene. However, when it is used in PCP formulation mixtures containing additional UV filters and preservatives, then the photostability of the final product may substantially increase [9] [10] [11] . Manova et al. (2013) assessed the frequency of occurrence of UV filters and their concentrations in various classes of PCPs and cosmetics and found that EHMC was present in 59 out of the 116 (51%) tested products, being actually present in every category (e.g. lipsticks, lip care products, liquid makeup, face creams, sunscreens, aftershaves and hand creams). It was most frequently found in lipsticks, face creams and liquid makeup products with median concentrations of 6.6%, 4.9% and 4.1%, respectively [9] .
EHMC is included in the European Union's database of >500 possible endocrine disruptors as a compound with limited knowledge about its health effects and worth further investigation based on accumulating evidence [12] . EHMC has been found to be persistent after longterm exposures, exhibiting estrogenic effects on MCF-7 cells [13] . According to in vitro and in vivo studies in animals, controlled exposure to EHMC altered estrogen and progesterone activity in rats resulting in changes of the uterus and reproductive organs of both genders [5, 14] . The no observed adverse effect level (NOAEL) for EHMC was 450 mg per kg bw and day using data from animal studies, while effects on fertility and reproductive health were observed above 1000 mg per kg bw and day [15] .
The lipophilicity and hydrophobicity are the main properties of UV filters that allow them to reach high dermal uptake rates and water resistance, a useful property for effective protection from the solar radiation in sunscreens and related products. However, lipophilic compounds such as the EHMC can relatively easily pass from the skin to the systemic circulation, where it has been measured in samples of blood, urine [16, 17] and breast milk [18] . Levels of EHMC in human plasma and urine have been measured after controlled application of sunscreen that contained the compound to 32 volunteers. The maximum median EHMC concentration in plasma was 7 ng/mL in postmenopausal females (4 hours after application) and 16 ng/mL in males (3 hours after application) [16] . In the same study 96 hours after the application of cream containing 10% of the compound, EHMC was detected in urine (maximum median for females 6 ng/mL and 3 ng/mL for males). However EHMC levels did not significantly (p>0.05) change from 24 to 96 hours after the cream application [16] .
Except for the controlled UV filter application studies in humans, no general population studies on the magnitude and variability of exposure to EHMC exist. Given the widespread use of UV filters in numerous consumer products, a pilot human biomonitoring study was undertaken. The objectives of the study were to: i) determine the concentrations of EHMC in urine samples of young adult volunteers (as a baseline exposure level to EHMC), and ii) investigate the association between consumption patterns of selected consumer products and urinary concentrations of EHMC.
Materials and methods

Study design -sample collection
A pilot human biomonitoring study was set up in Limassol, Cyprus during the spring of 2013. A randomlyselected group of 48 volunteers aged 18-36 (median=22 years), 24 males and 24 females, from the pool of students and staff of the Cyprus University of Technology agreed to participate in the study. The study was approved by the Cyprus National Bioethics Committee (EEBK/ EP/2012/34) and all participants signed informed consent forms. A detailed questionnaire was administered by trained personnel to capture habits regarding use of PCPs, sunscreens and cosmetics. The use of consumer products was investigated for the sunscreens (face, body, lip and hair sunscreen), cosmetics (foundation, lipstick, eyeshadow, eyeliner, rouge, mascara) and PCPs (shampoo, conditioner, shower gel, body lotion, perfume, deodorant, aftershave, nail polish). The day after the interview, each participant provided a first morning void urine sample in a sterilized polypropylene vial (50 mL). Urine samples were stored in chilled coolers during sample collection and subsequently stored at -80°C until the analysis. Participants were not asked to alter their consumption patterns of the aforementioned products the day before the sampling. Since the study aimed to measure the background/baseline exposure from routine use of the sunscreens, cosmetics and PCPs there was no control or specific criteria on product consumption patterns.
Chemicals and materials
High purity standards were used, including EHMC (98%, CAS number: 5466-77-3) and the internal standard decafluorobiphenyl (DFBP, 99%), both purchased from Sigma-Aldrich. Ethyl acetate (EtOAc) and methyl tert-butyl ether (MTBE) were purchased from Panreac and SigmaAldrich, respectively. Potassium dihydrogen phosphate, sodium hydroxide and potassium chloride were purchased from Fisher and Fluka.
A buffer solution at pH 7.2 was prepared using potassium dihydrogen phosphate and sodium hydroxide at 1.0 M total concentration for use during the liquidliquid extraction step. The initial standard solution of EHMC was prepared in ethyl acetate at a concentration of 5 mg/mL. Following, standard working solutions were prepared in both ethyl acetate and in pooled human urine (Supplementary Information section).
Sample preparation
Urine samples (n=48) were immediately coded after their collection and kept in the freezer at -80 o C. Samples were left to defrost the entire night before the day of their analysis. Several solvents including MTBE, isooctane, hexane and dichloromethane (DCM) were tested with respect to their effectiveness in clearly achieving a phase separation during the liquid-liquid extraction step of the EHMC method. The MTBE performed better than the rest of the solvents in effectively extracting most of the spiked EHMC levels.
Our urinary EHMC analytical method was modified after the method by March et al. (2009) for the determination of 2-ethyl 4-(dimethylamino) benzoate (EHDAB) in urine [19] . The procedure was as follows: 5 mL of urine were mixed with 0.5 gr of potassium chloride, 1 mL buffer (potassium dihydrogen phosphate, pH 7.2) and 2 mL MTBE. Samples were thoroughly vortexmixed and centrifuged for 10 min at 2,500 rpm. Following, 1.5 mL from the upper organic phase was collected into 2 mL amber glass vials and samples were taken to complete dryness with gaseous N 2 stream. Finally, 20 μL DFBP and 480 μL DCM were also added in each vial and the samples were vortex-mixed for 3 minutes.
Gas chromatography-mass spectrometry (GC-MS/MS) analysis
GC-MS/MS spectra were recorded on an Agilent 7890A GC equipped with an Agilent 7000 triple quadrupole MS detector, and programmed temperature vaporization (PTV) injector. A 20 μL sample was injected at a rate of 100 μL/min, while the inlet was maintained at 35°C for 0.35 min, ramped to 400°C for 5 min at a rate of 400°C/ min and following to 280°C at a rate of 400°C/min. Solvent was evaporated for 0.3 min at a flow rate of 30 mL/min at 0 psi and after 1.5 min of sample loading on the column; the purge valve was opened at a flow of 30 mL/min. Compounds were separated on an HP-5MS Column (30 m x 250 um x 0.25 um) (Agilent, USA) and helium carrier gas (99.995% purity) flow was maintained at 1 mL/min. The oven was set to 30°C for 2 min, ramped to 280°C at a rate 100°C/min where it was maintained for 5 min, followed by a post run period at 280°C for 1 min. MSD transfer line and MS source temperatures were held at 280°C, while quadruples were held at 150°C. Mass spectra were obtained using electron impact ionization (70 eV) with a solvent delay of 4.5 min.
Based on ion abundances in different collision energies, the parent-daughter ion pairs used for multiple reaction monitoring (MRM) were selected, while scanning cycles were kept constant to approximately 3 cycles per second. In brief, MS spectra of a standard solution were obtained and analytes were identified by comparison to NIST mass spectra library (NIST08). For each compound, molecular ion MS/MS spectra in different collision energies were obtained. Collision energies for the chosen parent-daughter ion pairs of each analyte were optimized to achieve maximum signal intensity. The table with the selected MRMs and the respective collision energies for EHMC and the internal standard can be found in the Supplementary Information (Table SI 2 A linear range of EHMC concentrations between 0.350 ng/mL -12.500 ng/mL was obtained with our analytical method in urine, with a limit of detection (LOD) of 0.105 ng/mL and a limit of quantification (LOQ) of 0.350 ng/mL. The LOD and LOQ were estimated using seven replicates of the concentration corresponding to the lowest calibration curve point in urine (100 ng/L), using the formulae: LOD = 3 x SD, and LOQ = 10 x SD (Table SI 3). Spectra of EHMC standard and actual urine samples can be found in the SI section ( Figure SI 3) . Creatinine measurements in urine were performed following a colorimetric (picric acid-based) UV-VIS test at 520 nm [20] .
Quality Control (QA/QC)
No cross-, or external, contamination was expected during the urine sample preparation and analyses because of the strict quality control measures, including the use of gloves and the thorough cleaning of glass laboratory equipment. We also confirmed that the researcher who performed the urinary EHMC measurements was not using sunscreens or cosmetics during the day of sample processing and analysis. A total of 15 quality control standards (QCs) were divided in triplicates that were included in each day's batch analysis (5 days). The QCs were blank urine samples spiked with a final concentration of 100 ng/L standard solution of EHMC. The average between-day and within-day reproducibility of the method were 14.5% and 5.5% respectively. Acceptable average QC recovery was obtained (90-102%) for the spiked EHMC urine samples with a standard deviation of up to 15%.
Statistical analyses
All statistical analyses were performed in R [21, 22] . Urinary EHMC levels below LOD were assigned ½ LOD, while those between LOD and LOQ were treated as ½ LOQ. Urinary EHMC concentrations were adjusted for urinary creatinine and ln-transformed, because their initial distribution of values was skewed. Descriptive statistics of the EHMC creatinine-adjusted and unadjusted concentrations, including geometric and arithmetic means, standard deviation, median values and percentiles were performed for each gender and the whole sample.
Comparison of the urinary EHMC levels between groups of participants was performed with the nonparametric Wilcoxon and Kruskal-Wallis tests for the creatinine-adjusted values. Linear multiple regression analysis was performed to assess possible associations between the ln-transformed creatinine-adjusted urinary EHMC levels and several a priori selected covariates. The first set of models included all the relevant variables and then the variables separated in categories. The variables that were significant (p-value < 0.10) in the initial models were included in the final. Since in most occasions, only females reported the use of cosmetics and/or other PCPs, such as body lotion, etc., the models were run again including only the female participants, including also the number of cosmetics used as a predictor variable. When the frequency of use of a product was reported as "rare" it was recoded as zero for the regression analysis. Collinearity of the predictor variables was assessed with the variance inflation factor (VIF); covariates with VIF values >5 were excluded and the regression models were re-run.
Results
Study population -demographic characteristics and urinary EHMC levels
With the exception of two males, all subjects had EHMC levels above LOD (Table SI 1 ). The geometric mean of urinary EHMC levels was 0.28 ng/mL and 0.44 ng/mL for males and females respectively, while the median creatinine-adjusted urinary levels of 111 ng/g for males were significantly lower (p=0.006) than those for the females (median: 257 ng/g) ( Table 1) . Similarly, significant differences were observed between the participants of the BMI categories < 25 kg m 2 (underweight) and 25-30 kg m 2 (p-value=0.03) using pairwise Wilcoxon test, but this was not the case for the obese group (> 30 kg m 2 ). The majority of the subjects (77%) reported being non-smokers. Among the 11 current smokers, six of them reported smoking > 10 cigarettes per day (max. 20 cigarettes per day) ( Table 1) .
Use of sunscreens, cosmetics and PCPs vs. urinary EHMC levels
As expected, females were the main users of sunscreens, cosmetics and PCPs in almost all product categories; aftershave lotion/cream was the only product that was exclusively used by males, with 50% of them using it at least once per week. Males did not report the use of any sunscreen or cosmetics during winter, at all. No participant reported the use of hair sunscreen, while only two females reported the use of lip sunscreen. Use of body sunscreens was reported only for the summer months by 79% of the participants (21 females and 17 males). Only 10 women mentioned all-year-long use of face sunscreens, while 10 participants (including 2 men) used the product only during summer ( Table 2) .
The creatinine-adjusted EHMC concentrations were not the same among all groups as defined by the use of face sunscreen (p-value=0.008), while no difference in urinary EHMC levels were observed between the users and no-users of body sunscreen (Table 2) . EHMC levels were different between the groups that mentioned no use of face sunscreens and those that used it all year long (p-value=0.002, pairwise Wilcoxon test). Pairwise comparison of the EHMC levels among the female participants that reported use of the product throughout the year, only during summer or no use of face sunscreen did not show any significant difference (α=0.05). The frequency of use of sunscreens differed for the two types that were most commonly used, i.e. the face and the body sunscreen (Figure SI 5, Figure SI 6 and Figure SI 7 ). Face sunscreen was primarily used during summer (75% of the females) as was body sunscreen (87% of the females) (Table SI 4 ).
The use of cosmetics, such as foundation, lipstick, eyeshadow, etc, was only reported by females ( Table 3 ). The comparison of the creatinine-adjusted urinary EHMC concentrations between those that mentioned the use of the cosmetic product and those that did not (including all male participants) showed a significant difference for foundation (p-value=0.03), lipstick (p-value=0.003), eyeshadow (p-value=0.002) and mascara (p-value=0.006) (Table SI 5 ). However, when the comparison was limited to females and the frequency of use for each cosmetic product was taken into consideration, no significant (p>0.05) differences in the creatinine-adjusted EHMC urinary levels were found with the Kruskal-Wallis test (Table SI 5) .
Regarding perfumes, deodorants and aftershave lotions, the first two products were used by both genders, while the aftershave lotion was only applied by men. Perfume was used by 47 out of 48 participants, 46 of them use it all year and only one participant mentioned its use for six months. Most subjects reported spraying the perfume directly on the skin (31 of the 47 only use perfumes directly on the skin and 14 on clothes and the skin) ( Table  SI 6 ). No significant differences were found in the urinary EHMC levels between the groups using perfume on skin, on the skin and clothes, and those spraying it on the clothes (data not shown). All male participants mentioned the use of aftershave lotion at least once a week and only one of them mentioned using hair conditioner once per week. As expected, all the volunteers used shampoo very Comparison of the OMC levels between the groups of participants were conducted with the Wilcoxon and Kruskal-Wallis test between the creatinine-adjusted concentrations. *NS indicates non-significant differences, else the p-value is noted in parenthesis.
frequently and the majority of females (n=18) also used hair conditioner. Differences in urinary EHMC levels were not statistically significant (p<0.05) between those using and those not using conditioner (Table SI 6 ); the same outcome was observed when the analysis was limited to females.
Determinants of Urinary EHMC levels
Linear multiple regression analysis showed that the use of face sunscreens (all year) (p-value=0.02) and gender (females) (p-value=0.03) were significant predictors of urinary EHMC levels in the pooled sample, even after adjusting for relevant covariates, such as age, BMI and the number of cosmetics used more than once per week (R 2 =0.30, p-value=0.011) ( Table 4) . When the regression model was stratified by gender, the use of face sunscreens remained significant (for the females) and the overall multiple R 2 value was 0.28 but the p-value for the model was statistically non-significant. Initial regression models were performed with the products categorized in groups and selected variables, but no strong association could be identified (Table SI 7 ). The reduced sample size (n=24) during gender stratification could perhaps explain the non-significance of the adjusted model. No significant (p>0.05) association between the absolute number of cosmetics used or the use of body sunscreens and the urinary EHMC levels was found for the whole sample (Table SI 8) ; similarly, there was no association between the number of cosmetics used more than once per week and the urinary EHMC levels.
Discussion
The present human biomonitoring study of a University student/staff subpopulation group (n=48) enabled us to quantify urinary EHMC concentrations and relate those to questionnaire responses about self reported usage of sunscreens, cosmetics and PCPs. Despite the exploratory nature of the study and the small sample size, the use of face sunscreens (all year long) was consistently and significantly (p-value=0.02) associated with the urinary EHMC levels. UV filters, like EHMC, may be included Comparison of the OMC levels between the groups of participants was conducted with the Wilcoxon and Kruskal-Wallis test between the creatinine-adjusted concentrations. The comparisons were performed when enough number of participants were included in each group. In the cases where comparison was not performed (i.e. for the use of body sunscreen by gender) it is indicated in parenthesis instead of the result of the comparison. *NS indicates non-significant differences; else the p-value is noted in parenthesis. Comparison of the EHMC levels between the groups of participants was conducted with the Kruskal-Wallis test between the creatinine-adjusted concentrations. *NS indicates non-significant differences; else the p-value is noted in parenthesis.
not only in sunscreens but also in other products and cosmetics (e.g., face creams) that additionally offer sun protection. It is often the case that sun-screening UV filters are included in face cream formulation mixtures. Face creams, which often contain UV filters, had one of the highest median EHMC concentrations (4.9%) among several classes of commercial sunscreens and cosmetics products [9] . The median EHMC concentrations for other classes of sunscreens and cosmetics products were: 3.4% in lip-care products, 4.1% in liquid makeup, and 6.6% in lipsticks. Smaller EHMC concentrations were also found in sunscreens (0.5%), hand creams (1.95%) and aftershave (2.9%) [9] . The reported (all year long) use of face sunscreens in this study in Cyprus indicated a chronic exposure scenario to UV filters. This study's urine sampling in the spring attempted to capture background exposures to UV filters because of limited use of certain UV filter-containing products (sunscreens) during that period of the year. However, certain products, like cosmetics that contain small amounts of UV-filters may be frequently used by females all year long. Cyprus is a Mediterranean country with summer peaks of mean air temperatures > 40°C and very high UV index values (>7.5) (http://www.uvnet.gr/ ) [23] . It seems reasonable that such meteorological conditions support the use of UV filter-containing products, and well-known products marketed in Europe are commonly sold in Cyprus, as well.
As anticipated, females reported higher frequency of use of cosmetics and sunscreens than males. The use of body sunscreen was only reported for the summer months, while our urine sampling took place before summer months (in spring); it was, thus, anticipated that the urinary EHMC levels could not be influenced by the reported use of body sunscreen during the summer months. The EHMC may not only be present in sunscreens, but also in other cosmetics, such as foundations or lipsticks [9, 11, 24] . Since we aimed to assess baseline levels of EHMC among young adults, there was no control over product use prior to urine sample collection. Differences in the EHMC levels were significant for the participants that reported the use of foundation, lipstick and eye-shadow; however this difference did not hold when the analysis was stratified by gender (females), or when they were categorized according to the frequency of use of each product.
Measured urinary EHMC levels in this study were lower than those measured in earlier studies, with a median of 0.38 ng/mL and a maximum of 1.38 ng/ mL. Twenty-four hours after controlled application of 2 mg/cm 2 cream containing 10% w/w EHMC in young men and postmenopausal women, median urinary EHMC levels were 4 ng/mL for both genders (range: 2-110 ng/mL, for the males and 1-29 ng/mL for the females) [16] [17] [18] . In the same studies, plasma EHMC levels reached a maximum median value after 3 and 4 hours of the dermal application for the male and female participants, respectively. A crossover study of UV filters did not report the detection of EHMC in the urine or plasma of volunteers receiving controlled application of a sunscreen formulation mixture, but their UV filter analytical method in urine had a high LOQ of 1 ng/mL, being higher than most of the EHMC values in our study [25] . Urinary EHMC levels have not been extensively used as a biomarker of exposure to this UV filter in the general population, and the half-life of elimination for EHMC is not adequately studied in crossover studies measuring the systemic absorption and urinary excretion of topical application of the compound [16, 17] . Studies showed that the anatomical site of application may influence skin penetration of sun-screening chemicals. Penetration of sun-screening substances through face epidermis can be up to four fold greater in magnitude than that occurring in back and arms [25] . A substantial amount of applied mass of the mixture of sun-screening chemicals, including EHMC (7.5 %, w/v), was found in the stratum corneum of 12 volunteer's back after 8 hours, while a portion of applied dose did not reach the deeper epidermis layers, since it was found in the superficial layers (4-10%) [25] . Factors regulating the overall skin condition, such as age of the product user may also play a role in the disposition of applied UV filters. The formulation in which the UV filters are contained in the products is also important, because free EHMC was shown to better penetrate the skin than EHMC in a suite of vehicles [26, 27] . The chemical composition of formulation vehicles containing the UV filters may also impact the magnitude of release and skin penetration rates of sun-screening compounds; maximal and minimal benzophenone-3 fluxes were observed from liquid paraffin and coconut oil, respectively, whereas an alcohol-based vehicle exhibited low benzophenone-3 release, but high skin penetration and retention [25] .
The above indicated the complexity of reliably assessing the magnitude of UV filters exposures. Exposure assessment for UV filters may be hindered by the fact that commercial sunscreen products usually consist of a mixture of UV filters. Thus, individual behavior of each UV filter may be distorted in the presence of other filters, changing absorption patterns or activating the production of toxic metabolites [5, 28] . The small sample size and the use of a single urine sample (first morning void) were important limitations of the present study, because we currently know nothing about the withinsubject variability of urinary EHMC levels. Given the fact that our aim was to perform a pilot assessment of EHMC exposure in a sample of young volunteers, the product usage patterns were not controlled before the urine samples collection and this was an important difference in the study design of the so far published EHMC human studies (crossover vs. cross-sectional study design). Also, our urinary sampling scheme was aimed to characterize baseline EHMC exposures, because it occurred during spring when most participants do not actively use sunscreens and only half of our study population (the females) were systematic users of cosmetics containing EHMC as their active ingredient [9] . This is the first pilot human biomonitoring study using urinary EHMC concentrations as a biomarker of exposure to EHMC from various consumer products in a small young adult and healthy group in Cyprus. Efforts in exposure reconstruction and modeling exercises to estimate the magnitude and uncertainty associated with the frequent use of UV filter-containing sunscreens and cosmetics may be complemented by internal dosimetry studies. Whether the urinary EHMC concentrations can be used as a valid biomarker of exposure, remains to be studied in detail by better understanding the toxicokinetics of EHMC disposition in the human body, quantifying the kinetics of EHMC elimination in urine, and whether bioactivation of EHMC metabolic products occurs. Only then, could we be utilizing such exposure measurements in questionnaires and exposure assessment protocols of relevant epidemiological studies. We could further evaluate the observed trends in our pilot study using a bigger homogeneous sample comprising females reporting frequent use of cosmetics or during the summer when the use of sunscreens is more common.
